The prognosis, chemotherapy and immunotherapy efficacy of the SUMOylation pathway signature and the role of UBA2 in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is one of the most common malignant tumors worldwide. Small Ubiquitin-like Modifier (SUMO)-ylation plays a crucial role in tumorigenesis. However, the SUMOylation pathway landscape and its clinical implications in LUAD remain unclear. Here, we analyzed genes involved in th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Aging (Albany, NY.) NY.), 2024-02, Vol.16 (5), p.4378-4395
Hauptverfasser:	Yu, Liying, Lin, Na, Ye, Yan, Zhuang, Haohan, Zou, Shumei, Song, Yingfang, Chen, Xiaoli, Wang, Qingshui
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma of Lung - drug therapy Adenocarcinoma of Lung - genetics Humans Immunotherapy Lung Neoplasms - drug therapy Lung Neoplasms - genetics Prognosis Research Paper Sumoylation Ubiquitin-Activating Enzymes - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!